Showcasing a new cGMP manufacturing facility and a world-class Quality Control Laboratory, Avantor's new hub is set to strengthen the region’s innovation and biopharma ecosystems.
Exyte to build Dexcom s first manufacturing facility in Asia
STUTTGART, Germany and PENANG, Malaysia, April 15, 2021 /PRNewswire/ Exyte, world-renowned for the design and construction of high-tech facilities, has been awarded a fast-track project for Dexcom in Penang, Malaysia. This is the first manufacturing facility for the U.S.-based diabetes care technology provider outside the United States.
Exyte is proud to support Dexcom s strategic growth plans as it expands manufacturing into Asia for the first time. Located in Batu Kawan, Penang, and with 1.8 million square feet of gross floor area, the project will house a manufacturing facility for continuous glucose monitoring (CGM) systems. Key parts of the facility include multi-story cleanrooms, a warehouse with dock leveller, a three-story Central Utility Building (CUB), a seven-story office building with a canteen and recreational area as well as a seven-level multi-story parking structure.